Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843413 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
A Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT01843413: Active Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor, sponsored by Case Comprehensive Cancer Center.
NCT01843413 is a Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 33 participants, below the 106-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01843413, a Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I/II trial studies the side effects and the best dose of stereotactic radiosurgery and to see how well it works in treating patients with large brain metastases. Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE cognitive assessment
- RADIATION stereotactic radiosurgery
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-07-02 |
| Est. Completion | 2025-08 |
| Phase | Phase 1 |
What the registry record for NCT01843413 still lists
NCT01843413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 106-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Tumors Metastatic to Brain appearing as the primary indexed condition, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT01843413 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01843413 about?
NCT01843413 is a clinical study titled "Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases". This phase I/II trial studies the side effects and the best dose of stereotactic radiosurgery and to see how well it works in treating patients with large brain metastases. Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT01843413?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2013-07-02. Estimated completion is 2025-08.
What conditions does trial NCT01843413 study?
This clinical trial studies the following conditions: Tumors Metastatic to Brain, Unspecified Adult Solid Tumor.
What interventions are being tested in trial NCT01843413?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), cognitive assessment (PROCEDURE), stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT01843413?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01843413 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors Metastatic to Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
RECRUITING · Phase 1
-
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
COMPLETED · Phase 1
-
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
COMPLETED · Phase 2
-
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI